Hosted by the DNB//Back Bay Healthcare Partnership in collaboration with Nasdaq Nordic, NAHC 2025 stands as an exclusive, invitation-only event, and the largest US-Nordic healthcare conference in the US. NAHC serves as a premier platform, uniting large and mid-cap public and private IPO-ready US and Nordic life science companies. All presenting companies will showcase leading products that offer substantial advancements in patient care, making them highly appealing investment opportunities.
We take pride in the transformative impact of NAHC-presented companies and uphold stringent criteria for participation. NAHC operates on a no-fee basis, generously funded by organizations committed to advancing the most promising innovations in the market.
Together, we remain steadfast in our commitment to propelling the most promising Nordic healthcare innovations onto the global stage and we are proud to present them alongside highly relevant discussions and US-based companies that are complementary to their offerings.
Attendance at this event is strictly by invitation for qualified investors and active participants in the biopharma, medtech, healthtech and pharmaceutical sectors.
Date: March 26 – 27, 2025
Time: 8:00 AM – 5:00 PM EST
Venue: Shearman & Sterling Conference Center, 599 Lexington Ave @ 52nd St., New York City
Click here to learn more.